MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, common...
$8,209,703
Proceeds from issuance of
common stock in atm...
$312,574
Net cash provided by
financing activities
$8,409,031
Canceled cashflow
$113,246
Net decrease in cash
and cash...
$2,819,545
Canceled cashflow
$5,589,486
Repayment of short-term
debt
$113,246
Stock-based compensation
expense
$458,379
Accounts payable
$325,332
Prepaid expenses and
other current assets
-$99,037
Change in fair value of
warrant liabilities
$27,816
Prepaid clinical trial
costs (current and...
-$22,705
Net cash used in
operating activities
-$5,589,486
Canceled cashflow
$933,269
Net loss
-$4,010,773
Accrued expenses and
other current...
-$2,511,982
Back
Back
Cash Flow
source: myfinsight.com
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)